Blog - Nad Research, Inc.

March 24, 2023March 29, 2023

An exciting time for NAD research: An interview with Dr. Susan Broom Gibson

Susan Broom Gibson, PhD, is an associate professor of psychology, School of Natural and Behavioral Sciences, William Carey University, in Hattiesburg, MS, a research consultant for Springfield Wellness Center, and co-chairs the advisory board of NAD Research, Inc. She received her PhD in experimental psychology from the University of Mississippi in 2002 and completed research associate/fellowship positions at Boston University School of Medicine and Tulane University School of Medicine. Her areas of specialty include: the neuro-mechanisms of drug abuse and withdrawal, animal models of drug abuse and stress, and alternative treatment for substance use disorders.

Over the past 15 years she has conducted research in the therapeutic potential of IV administration of NAD for the treatment of acute withdrawal symptoms associated with substance use disorders and Parkinson’s, and in the therapeutic potential of intranasal (sphenocatheter) administration of NAD for migraines and the maintenance of symptoms associated with Parkinson’s Disease. She spoke with us via Zoom in March 2023.

February 23, 2023March 25, 2023

Utilizing light to optimize intravenous NAD effectiveness

An interview with Michael Payne, MS, CRC, CNS

Michael Payne is perhaps the world’s leading specialist in the field of photobiomodulation therapy (PBMT) and NAD supplementation.

PBMT utilizes non-ionizing forms of light (including LASERS, LEDs, and broadband light) in the visible and near infrared spectrum. Without involving heat, it activates endogenous chromophores to begin photophysical and photochemical processes.

There are numerous examples of light-induced photochemical reactions in biological systems. Vision, for example, results when light interacts with photosensitive cells in our retinas, which convert light energy into electrical signals that are transmitted to the visual processing centers of the brain. Similarly, our skin produces vitamin D as a result of sunlight activating a form of cholesterol, 7-dehydrocholesterol, converting it to vitamin D3. The negative effects of the absence of light on the human body are also well known. Two examples include seasonal affective disorder (SAD) and lack of vitamin D production leading to rickets.

Continue reading “Utilizing light to optimize intravenous NAD effectiveness“

January 4, 2023January 8, 2023

In a nutshell: summarizing our current knowledge of NAD and where we go next

An interview with Dr. Ross Grant

Dr. Ross Grant is a biochemical pharmacologist and CEO of the Australasian Research Institute at Sydney Adventist Hospital. Dr. Grant has co-authored more than 100 academic articles in his research area, which focuses on understanding how a person’s lifestyle factors change their body’s biochemistry and immune activity, driving it toward either health or disease. In particular, he is interested in the influence of lifestyle factors on natural killer (NK) cell activity, redox balance (oxidative stress), and NAD+ metabolism, and how these influence cellular degeneration, particularly in the brain and central nervous system. He is a member of the Australian Neuroscience society (ANS), Nutrition Society of Australia (NSA), Australasian Society of Lifestyle Medicine, serves on the Advisory Board of NAD Research, Inc., and is one of our primary research partners.

November 28, 2022January 5, 2023

Boosting intracellular NAD levels: An interview with Dr. Jin-Xiong She

Dr. Jin-Xiong She completed his undergraduate education in China and his PhD degree in Molecular and Population Genetics in France. After a short postdoctoral training at the University of Florida (UF), he was promoted to Assistant Professor, Associate Professor, Full and Endowed Professor. He served as Division Chief of Experimental Pathology and Director of Research of the UF’s world-class Diabetes Center. In 2002, Dr. She was recruited to be the Georgia Research Alliance Eminent Scholar in Genomic Medicine at the Medical College of Georgia. He was the founding Director of the Center for Biotechnology and Genomic Medicine, Professor of the Departments of Obstetrics and Gynecology and Department of Health Technologies as well as the director of two core research facilities for Augusta University (Genomics, Proteomics & Mass Spectrometry). In his long academic career, he has authored over 400-peer reviewed papers with an H-Index of 74 and over 17,000 citations, secured over $100 million in research grants, and has been invited to speak all over the world. He also has mentored 15 doctoral students, over 50 post-docs, and 12 faculty members. Named one of the 20 “Georgia Top Medical Researchers” in 2014 by the Atlanta Business Chronicle, he served as President of the Chinese Geneticists in America and President of the American Diabetes Association’s council on Immunology, transplantation and Immunogenetics, among other honors. Currently he is the founder, CEO, and Chief Scientific Officer of Jinfiniti Precision Medicine.

September 27, 2022January 5, 2023

Dr. Richard F. Mestayer, III, on exciting developments in NAD research

Doc with patient - NAD Research — Dr. Richard F. Mestayer with a patient at Springfield Wellness Center.

Editor’s Note: With the following interview with Dr. Richard F. Mestayer, III, medical director of NAD Research and of Springfield Wellness Center, we begin a series of blog posts updating BR+ Fellows, BR+NAD Brain Restoration Summit attendees, and others on the most exciting developments we’re tracking in NAD research. If you are aware of, or conducting, research you’d like to bring to our attention, please let us know by emailing leslee@alchemyondemand.com.